71.07KUSD
-0.06
Type
Common Stock
Exchange
OTCQB
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US3714853013
CUSIP
371485103
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
July
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.48
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-0.373
Wall Street Target Price
6.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
692,762
Gross Profit TTM
2,081,539
EBITDA
-33,303,532
Profit Margin
0.00%
Return On Assets TTM
-43.84%
Return On Equity TTM
-1772.71%
Revenue Per Share TTM
0.007
Qtly Revenue Growth YOY
-95.90%
Diluted Eps TTM
-0.373
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.1026
Price Book MRQ
0
Enterprise Value Revenue
11
Enterprise Value EBITDA
0
5.95
2.41%77.70
1.33%603.00
0.57%493.99
0.33%20.59
0.22%61.55
0.08%2.74
0.00%102.75
-14.75%150.00
-2.18%27.28
-0.40%